PortfoliosLab logo
OPRA vs. PATH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OPRA and PATH is 0.58, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

OPRA vs. PATH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Opera Limited (OPRA) and UiPath Inc. (PATH). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%NovemberDecember2025FebruaryMarchApril
91.83%
-83.20%
OPRA
PATH

Key characteristics

Sharpe Ratio

OPRA:

0.26

PATH:

-0.71

Sortino Ratio

OPRA:

0.80

PATH:

-0.72

Omega Ratio

OPRA:

1.09

PATH:

0.89

Calmar Ratio

OPRA:

0.23

PATH:

-0.46

Martin Ratio

OPRA:

1.01

PATH:

-1.07

Ulcer Index

OPRA:

13.54%

PATH:

38.01%

Daily Std Dev

OPRA:

52.18%

PATH:

57.65%

Max Drawdown

OPRA:

-72.85%

PATH:

-88.50%

Current Drawdown

OPRA:

-39.51%

PATH:

-86.38%

Fundamentals

Market Cap

OPRA:

$1.39B

PATH:

$6.24B

EPS

OPRA:

$0.90

PATH:

-$0.13

PS Ratio

OPRA:

2.89

PATH:

4.37

PB Ratio

OPRA:

1.46

PATH:

3.38

Total Revenue (TTM)

OPRA:

$524.83M

PATH:

$1.43B

Gross Profit (TTM)

OPRA:

$281.63M

PATH:

$1.18B

EBITDA (TTM)

OPRA:

$117.51M

PATH:

-$148.55M

Returns By Period

In the year-to-date period, OPRA achieves a -16.29% return, which is significantly lower than PATH's -8.81% return.


OPRA

YTD

-16.29%

1M

-10.70%

6M

-3.80%

1Y

22.39%

5Y*

30.12%

10Y*

N/A

PATH

YTD

-8.81%

1M

6.62%

6M

-6.15%

1Y

-40.44%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OPRA vs. PATH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OPRA
The Risk-Adjusted Performance Rank of OPRA is 6262
Overall Rank
The Sharpe Ratio Rank of OPRA is 6363
Sharpe Ratio Rank
The Sortino Ratio Rank of OPRA is 6161
Sortino Ratio Rank
The Omega Ratio Rank of OPRA is 5858
Omega Ratio Rank
The Calmar Ratio Rank of OPRA is 6464
Calmar Ratio Rank
The Martin Ratio Rank of OPRA is 6565
Martin Ratio Rank

PATH
The Risk-Adjusted Performance Rank of PATH is 1919
Overall Rank
The Sharpe Ratio Rank of PATH is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of PATH is 1919
Sortino Ratio Rank
The Omega Ratio Rank of PATH is 1616
Omega Ratio Rank
The Calmar Ratio Rank of PATH is 2323
Calmar Ratio Rank
The Martin Ratio Rank of PATH is 2626
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OPRA vs. PATH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Opera Limited (OPRA) and UiPath Inc. (PATH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for OPRA, currently valued at 0.26, compared to the broader market-2.00-1.000.001.002.003.00
OPRA: 0.26
PATH: -0.71
The chart of Sortino ratio for OPRA, currently valued at 0.80, compared to the broader market-6.00-4.00-2.000.002.004.00
OPRA: 0.80
PATH: -0.72
The chart of Omega ratio for OPRA, currently valued at 1.09, compared to the broader market0.501.001.502.00
OPRA: 1.09
PATH: 0.89
The chart of Calmar ratio for OPRA, currently valued at 0.23, compared to the broader market0.001.002.003.004.005.00
OPRA: 0.23
PATH: -0.46
The chart of Martin ratio for OPRA, currently valued at 1.01, compared to the broader market-5.000.005.0010.0015.0020.00
OPRA: 1.01
PATH: -1.07

The current OPRA Sharpe Ratio is 0.26, which is higher than the PATH Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of OPRA and PATH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
0.26
-0.71
OPRA
PATH

Dividends

OPRA vs. PATH - Dividend Comparison

OPRA's dividend yield for the trailing twelve months is around 5.15%, while PATH has not paid dividends to shareholders.


TTM20242023
OPRA
Opera Limited
5.15%4.22%9.07%
PATH
UiPath Inc.
0.00%0.00%0.00%

Drawdowns

OPRA vs. PATH - Drawdown Comparison

The maximum OPRA drawdown since its inception was -72.85%, smaller than the maximum PATH drawdown of -88.50%. Use the drawdown chart below to compare losses from any high point for OPRA and PATH. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%NovemberDecember2025FebruaryMarchApril
-39.51%
-86.38%
OPRA
PATH

Volatility

OPRA vs. PATH - Volatility Comparison

Opera Limited (OPRA) has a higher volatility of 21.79% compared to UiPath Inc. (PATH) at 17.46%. This indicates that OPRA's price experiences larger fluctuations and is considered to be riskier than PATH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
21.79%
17.46%
OPRA
PATH

Financials

OPRA vs. PATH - Financials Comparison

This section allows you to compare key financial metrics between Opera Limited and UiPath Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items